Institute for Human Genetics (IHG), University of California, San Francisco, San Francisco, CA, USA.
Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Nat Methods. 2021 Aug;18(8):903-911. doi: 10.1038/s41592-021-01222-3. Epub 2021 Aug 5.
The development of DNA-barcoded antibodies to tag cell surface molecules has enabled the use of droplet-based single-cell sequencing (dsc-seq) to profile protein abundances from thousands of cells simultaneously. As compared to flow and mass cytometry, the high per cell cost of current dsc-seq-based workflows precludes their use in clinical applications and large-scale pooled screens. Here, we introduce SCITO-seq, a workflow that uses splint oligonucleotides (oligos) to enable combinatorially indexed dsc-seq of DNA-barcoded antibodies from over 10 cells per reaction using commercial microfluidics. By encoding sample barcodes into splint oligos, we demonstrate that multiplexed SCITO-seq produces reproducible estimates of cellular composition and surface protein expression comparable to those from mass cytometry. We further demonstrate two modified splint oligo designs that extend SCITO-seq to achieve compatibility with commercial DNA-barcoded antibodies and simultaneous expression profiling of the transcriptome and surface proteins from the same cell. These results demonstrate SCITO-seq as a flexible and ultra-high-throughput platform for sequencing-based single-cell protein and multimodal profiling.
DNA 编码抗体的发展使得基于液滴的单细胞测序(dsc-seq)能够同时对数千个细胞的蛋白质丰度进行分析。与流式细胞术和质谱流式细胞术相比,目前基于 dsc-seq 的工作流程每细胞成本过高,限制了其在临床应用和大规模组合筛选中的使用。在这里,我们介绍了 SCITO-seq,这是一种工作流程,它使用拼接寡核苷酸(oligos)来实现超过 10 个细胞/反应的 DNA 编码抗体的组合索引 dsc-seq,使用商业微流控技术。通过将样本条形码编码到拼接寡核苷酸中,我们证明了多重 SCITO-seq 可以产生可重复的细胞组成和表面蛋白表达的估计值,与质谱流式细胞术相当。我们进一步展示了两种改良的拼接寡核苷酸设计,这些设计扩展了 SCITO-seq 的兼容性,实现了对商业 DNA 编码抗体的兼容,并能够同时从同一细胞中同时表达转录组和表面蛋白的分析。这些结果表明,SCITO-seq 是一种灵活且超高通量的基于测序的单细胞蛋白质和多模式分析平台。